Vetsys Pharmaceutical
Vetsys Pharmaceutical
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) has emerged as a titan in the animal pharmaceutical sector. With a robust registered capital of 30 million RMB, we have dedicated nearly two decades to perfecting the art of veterinary medicine. Our facility is a marvel of modern engineering, housing specialized workshops for powders, premixes, injections, oral solutions, and our flagship Intramammary Infusions.
Operating under strict Good Manufacturing Practices (GMP), Vetsys ensures that every syringe of infusion leaving our factory meets the rigorous international standards for safety and efficacy. By 2015, our commitment to excellence propelled us to achieve annual domestic sales exceeding USD 20 million, cementing our status as one of China's top animal pharmaceutical producers.
The global dairy industry faces a persistent challenge: Bovine Mastitis. As the single most costly disease in dairy farming worldwide, the demand for high-quality intramammary infusions has skyrocketed. In regions like Europe, North America, and the emerging dairy hubs in Southeast Asia and Africa, farm managers are increasingly seeking evidence-based pharmaceutical interventions to protect their herds and ensure milk quality.
Current industrial trends indicate a shift towards Targeted Antibiotic Therapy. With the rise of antibiotic resistance awareness, the industry is moving toward precision medicine. Products like Cefquinome Sulfate and the combination of Ampicillin and Cloxacillin are at the forefront of this evolution, providing broad-spectrum coverage against pathogens like Staphylococcus aureus and Streptococcus uberis while minimizing the risk of systemic resistance.
What sets Vetsys apart is our relentless pursuit of technological advancement. We don't just manufacture; we innovate. Our independent research institute is equipped with five specialized laboratories where a team of world-class scientists works tirelessly. This R&D powerhouse allows us to develop advanced formulations that offer better bioavailability and shorter withdrawal periods, which is a critical requirement for modern dairy operations.
Our research focuses on the stability of active pharmaceutical ingredients (APIs) in oily or aqueous bases, ensuring that our intramammary infusions maintain their potency even in varying climates—a major advantage for global exporters and importers in tropical or sub-arctic regions.
At Vetsys, quality is not a department; it is our cornerstone. Our comprehensive quality management system oversees the entire lifecycle of a product—from raw material sourcing to the final packaging. By adhering to ISO and GMP standards, we provide our global partners with the reliability they need to maintain trust in their local markets. Excellence in product quality is essential for the long-term sustainability of the animal health industry, and we take this responsibility seriously.
Precision Mold Injection
Ensuring leak-proof syringes for safe intramammary application.
Ultrasonic Welding
High-tech sealing technology for sterile pharmaceutical integrity.
Automated Assembly
Robotic precision in assembling veterinary delivery systems.
Sterile Packaging
Final stage quality checks and moisture-proof packing.
Global pharmaceutical buyers, ranging from large-scale agricultural cooperatives to government veterinary departments, are focusing on Local Adaptation. In the Middle East, heat stability is paramount. In Latin America, cost-efficiency and large-volume availability drive procurement. Vetsys addresses these needs through our diverse product line, offering specialized infusions for both Lactating Cows (rapid clearance) and Dry Cows (prolonged protection).
Local application scenarios vary significantly. For instance, "Dry Cow Therapy" is now a standard protocol in modern dairy farming to prevent new infections during the non-lactating period and to cure existing subclinical mastitis. Our Cefquinome Sulfate Intramammary Infusion (Dry Cow) is specifically engineered for this critical phase, offering high persistence and superior antimicrobial activity.
The advantage of sourcing from a premier Chinese manufacturer like Vetsys lies in the perfect synergy of Scale, Speed, and Sustainability.
At Vetsys, we are driven by a mission to improve animal well-being through continuous innovation. Our vision includes expanding our manufacturing capabilities to meet the increasing demand for safe, effective, and sustainable animal drugs worldwide. We remain committed to creating value for our customers, employees, and society as we shape the future of veterinary healthcare.
